Galafold FDA Approval History
FDA Approved: Yes (First approved August 10, 2018)
Brand name: Galafold
Generic name: migalastat
Dosage form: Capsules
Company: Amicus Therapeutics
Treatment for: Fabry Disease
Galafold (migalastat) is an alpha-galactosidase A (alpha-Gal A) pharmacological chaperone indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant.
Development timeline for Galafold
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.